- Home
- PLUR vs POCI Comparison
PLUR vs POCI Comparison
Compare PLUR & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- POCI
- Stock Information
- Founded
- PLUR 2001
- POCI 1982
- Country
- PLUR Israel
- POCI United States
- Employees
- PLUR N/A
- POCI N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PLUR Health Care
- POCI Health Care
- Exchange
- PLUR Nasdaq
- POCI Nasdaq
- Market Cap
- PLUR 36.9M
- POCI 33.4M
- IPO Year
- PLUR N/A
- POCI N/A
- Fundamental
- Price
- PLUR $3.95
- POCI $4.55
- Analyst Decision
- PLUR Strong Buy
- POCI
- Analyst Count
- PLUR 1
- POCI 0
- Target Price
- PLUR $12.00
- POCI N/A
- AVG Volume (30 Days)
- PLUR 52.1K
- POCI 26.3K
- Earning Date
- PLUR 11-12-2025
- POCI 11-13-2025
- Dividend Yield
- PLUR N/A
- POCI N/A
- EPS Growth
- PLUR N/A
- POCI N/A
- EPS
- PLUR N/A
- POCI N/A
- Revenue
- PLUR $1,326,000.00
- POCI $21,575,039.00
- Revenue This Year
- PLUR $97.38
- POCI N/A
- Revenue Next Year
- PLUR $293.97
- POCI N/A
- P/E Ratio
- PLUR N/A
- POCI N/A
- Revenue Growth
- PLUR 121.74
- POCI 13.67
- 52 Week Low
- PLUR $3.22
- POCI $3.77
- 52 Week High
- PLUR $7.13
- POCI $5.48
- Technical
- Relative Strength Index (RSI)
- PLUR 48.02
- POCI 53.95
- Support Level
- PLUR $3.50
- POCI $4.26
- Resistance Level
- PLUR $4.12
- POCI $4.90
- Average True Range (ATR)
- PLUR 0.37
- POCI 0.31
- MACD
- PLUR 0.03
- POCI 0.02
- Stochastic Oscillator
- PLUR 36.83
- POCI 37.53
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.